Method of using IL-11 for treating mucositis
US6887461B1 · kind B1 · utility
1Cited by
9References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2000 |
| Grant date | May 3, 2005 |
| Priority date | — |
| Expiry date | May 1, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/006
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided by the present invention are topical formulations of Interleukin-11 and methods for treating a variety of disorders, including inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis, indeterminate colitis, and infectious colitis), mucositis (e.g., oral mucositis, gastrointestinal mucositis, nasal mucositis, and proctitis), necrotizing enterocolitis, inflammatory skin disorders (e.g., psoriasis, atopic dermatitis, and contact hypersensitivity), aphthous ulcers, pharyngitis, esophagitis, peptic ulcers, gingivitis, periodontitis, and ocular diseases (e.g., conjunctivitis, retinitis, and uveitis).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.